# Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

> **NCT03885180** · NA · UNKNOWN · sponsor: **Wuhan Asia Heart Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Valve Heart Disease
- Anticoagulants; Increased

## Interventions

- **DRUG:** Warfarin Sodium

## Key facts

- **NCT ID:** NCT03885180
- **Lead sponsor:** Wuhan Asia Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-20
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-03-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03885180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03885180, "Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03885180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*